The 12th Asia-Pacific Primary Liver Cancer Expert Meeting (2022APPLE), hosted by the APPLE Committee, supported by the China Primary Health Care Foundation, and organized by the Oncology Branch of the Chinese Medical Association, the Surgeon Branch of the Chinese Medical Doctor Association, the Liver Cancer Professional Committee of the Chinese Anti-Cancer Association, and Zhongshan Hospital,Fudan University, will be arranged as a virtual or hybrid meeting entitled “New perspectives in the era of targeted and immunological therapies for liver cancer”, which to be held in Shanghai, China, on the 12-14 August 2022.
Established in 2013, the APPLE Association is a worldwide leading academic organization for primary liver cancer. Targeting mainly at facilitating the scientific management of liver cancer diagnosis and treatment, exchanging information and reaching consensus in the field of liver cancer, it expects to advance the basic education and clinical diagnosis and treatment of liver cancer by means of academic exchanges such as clinical and scientific research of liver cancer.
International well-known experts and domestic experts in the field of liver cancer will be invited to this meeting to have discussions on the molecular pathogenesis and pathology of HCC, surgery and liver transplantation for HCC, locoregional therapy for HCC: new roles in immunotherapy era, systemic therapy for earlier-stages of HCC, cholangiocarcinoma, systemic therapy for advanced HCC etc., so as to jointly explore new strategies for the treatment of liver cancer. We look forward to meeting you at the meeting in August in Shanghai to seek common development and look into the future.